This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Microbial integrity testing for preservative-free drug formulations
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions
Interview with Guillaume Brouet on Aptar Pharma Services
Publications, Pharmaceutical, Innovation & Insights
Aptar Pharma provides guidance on FDA regulatory framework for OINDPs
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Connected Medicine: Insights from Payers and Other Stakeholders
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions, Innovation & Insights
